Founder effect of the Glu89Gln TTR mutation in the Bulgarian population

References

• Adams D, Lozeron P, Lacroix C. Amyloid neuropathies. Curr Opin Neurol. 2012;25:564–572.
   PubMed Web of Science ®Google Scholar
• Adams D. Hereditary and acquired amyloid neuropathies. J Neurol. 2001;248:647–657.
   PubMed Web of Science ®Google Scholar
• Parman Y, Adams D, Obici L, et al. Sixty years of transthyretin familial amyloid polyneuropathy (TTR-FAP) in Europe: where are we now? A European network approach to defining the epidemiology and management patterns for TTR-FAP. Curr Opin Neurol. 2016;29:S3–S13.
   PubMed Web of Science ®Google Scholar
• Ando Y, Coelho T, Berk JL, et al. Guideline of transthyretin-related hereditary amyloidosis for clinicians. Orphanet J Rare Dis. 2013;8:31.
   PubMed Web of Science ®Google Scholar
• Barreiros AP, Galle PR, Otto G. Familial amyloid polyneuropathy. Dig Dis. 2013;31:170–174.
   PubMed Web of Science ®Google Scholar
• Benson MD, Buxbaum JN, Eisenberg DS, et al. Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee. Amyloid. 2018;25:215–219.
   PubMed Web of Science ®Google Scholar
• Rowczenio DM, Noor I, Gillmore JD, et al. Online registry for mutations in hereditary amyloidosis including nomenclature recommendations. Human Mutat. 2014;35:E2403–2412.
   PubMed Web of Science ®Google Scholar
• Plante-Bordeneuve V, Said G. Familial amyloid polyneuropathy. Lancet Neurol. 2011;10:1086–1097.
   PubMed Web of Science ®Google Scholar
• Rapezzi C, Perugini E, Salvi F, et al. Phenotypic and genotypic heterogeneity in transthyretin-related cardiac amyloidosis: towards tailoring of therapeutic strategies? Amyloid. 2006;13:143–153.
   PubMed Web of Science ®Google Scholar
• Saraiva MJ, Birken S, Costa PP, et al. Amyloid fibril protein in familial amyloidotic polyneuropathy, Portuguese type. Definition of molecular abnormality in transthyretin (prealbumin). J Clin Invest. 1984;74:104–119.
   PubMed Web of Science ®Google Scholar
• Zaros C, Genin E, Hellman U, et al. On the origin of the transthyretin Val30Met familial amyloid polyneuropathy. Ann Hum Genet. 2008;72:478–484.
   PubMed Web of Science ®Google Scholar
• Iorio A, De Angelis F, Di Girolamo M, et al. Most recent common ancestor of TTR Val30Met mutation in Italian population and its potential role in genotype-phenotype correlation. Amyloid. 2015;22:73–78.
   PubMed Web of Science ®Google Scholar
• Soares ML, Coelho T, Sousa A, et al. Haplotypes and DNA sequence variation within and surrounding the transthyretin gene: genotype-phenotype correlations in familial amyloid polyneuropathy (V30M) in Portugal and Sweden. Eur J Hum Genet. 2004;12:225–237.
   PubMed Web of Science ®Google Scholar
• Dardiotis E, Koutsou P, Papanicolaou EZ, et al. Epidemiological, clinical and genetic study of familial amyloidotic polyneuropathy in Cyprus. Amyloid. 2009;16:32–37.
   PubMed Web of Science ®Google Scholar
• Buades Reines J, Ripoll Vera T, Uson Martin M, et al. Epidemiology of transthyretin-associated familial amyloid polyneuropathy in the Majorcan area: Son Llàtzer Hospital descriptive study. Orphanet J Rare Dis. 2014;9:29.
   PubMed Web of Science ®Google Scholar
• Almeida MR, Ferlini A, Forabosco A, et al. Two transthyretin variants (TTR Ala-49 and TTR Gln-89) in two Sicilian kindreds with hereditary amyloidosis. Hum Mutat. 1992;1:211–215.
   PubMedGoogle Scholar
• Ohmori H, Ando Y, Makita Y, et al. Common origin of the Val30Met mutation responsible for the amyloidogenic transthyretin type of familial amyloidotic polyneuropathy. J Med Genet. 2004;41:e51.
   PubMed Web of Science ®Google Scholar
• Excoffier LG, Laval S. Schneider Arlequin ver. 3.0: an integrated software package for population genetics data analysis. Evol Bioinformat Online. 2005;1:47–50.
   PubMed Web of Science ®Google Scholar
• Deligiannis P. The sea peoples: history, weaponry and a detailed list of their tribes (13th-12th century BC), 2012 [cited 2018 Nov 5]. Available from: https://periklisdeligiannis.wordpress.com/2012/12/02/the-sea-peoples-history-weaponry-and-a-detailed-list-of-their-tribes-13th-12th-century-bc/
   Google Scholar
• Ikeda S, Nakazato M, Ando Y, et al. Familial transthyretin-type amyloid polyneuropathy in Japan: clinical and genetic heterogeneity. Neurology. 2002;58:1001–1007.
   PubMed Web of Science ®Google Scholar
• Perfetto F, Frusconi S, Bergesio F, et al. The Val142Ile transthyretin cardiac amyloidosis: more than an Afro-American pathogenic variant. J Community Hosp Intern Med Perspect. 2015;5:26931.
   PubMed Web of Science ®Google Scholar
• Sikora JL, Logue MW, Chan GG, et al. Genetic variation of the transthyretin gene in wild-type transthyretin amyloidosis (ATTRwt). Hum Genet. 2015;134:111–121.
   PubMed Web of Science ®Google Scholar
• Olsson M, Norgren N, Obayashi K, et al. A possible role for miRNA silencing in disease phenotype variation in Swedish transthyretin V30M carriers. BMC Med Genet. 2010;11:130.
   PubMed Web of Science ®Google Scholar